Assignee
UNITED THERAPEUTICS CORP
US·104 granted patents·84 pending applications·2,643 citations·filing 1998–2025
Top patents by PatentIndex Score
188 records- 0199US9050311B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jun 9, 2015·59 cites·11 claims
- 0299US6700025B2Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2001·Granted Mar 2, 2004·121 cites·13 claims
- 0398US11292758B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2021·Granted Apr 5, 2022·3 cites·12 claims
- 0498US9624156B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Apr 18, 2017·30 cites·31 claims
- 0598US9593061B2Synthesis of intermediates for producing prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 14, 2017·13 cites·22 claims
- 0698US9422223B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Aug 23, 2016·44 cites·16 claims
- 0798US9278901B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 8, 2016·47 cites·12 claims
- 0898US9156786B2Process to prepare treprostinil, the active ingredient in remodulin®UNITED THERAPEUTICS CORP·Filed 2013·Granted Oct 13, 2015·44 cites·15 claims
- 0998US7544713B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 9, 2009·108 cites·26 claims
- 1098US7417070B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2004·Granted Aug 26, 2008·155 cites·3 claims
- 1198US7384978B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2006·Granted Jun 10, 2008·138 cites·14 claims
- 1297US9878972B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2016·Granted Jan 30, 2018·19 cites·34 claims
- 1397US9199908B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2014·Granted Dec 1, 2015·46 cites·11 claims
- 1497US8748657B2Process to prepare treprostinilUNITED THERAPEUTICS CORP·Filed 2013·Granted Jun 10, 2014·29 cites·7 claims
- 1597US8350079B2Treprostinil formulationUNITED THERAPEUTICS CORP·Filed 2009·Granted Jan 8, 2013·66 cites·11 claims
- 1697US8349892B2Solid formulations of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2010·Granted Jan 8, 2013·70 cites·33 claims
- 1797US6528688B2Prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2002·Granted Mar 4, 2003·95 cites·12 claims
- 1897US6441245B1Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2000·Granted Aug 27, 2002·118 cites·10 claims
- 1996US11839631B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2020·Granted Dec 12, 2023·3 cites·10 claims
- 2096US11839596B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2021·Granted Dec 12, 2023·3 cites·7 claims
- 2196US11141393B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2018·Granted Oct 12, 2021·9 cites·10 claims
- 2296US10716793B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2020·Granted Jul 21, 2020·11 cites·8 claims
- 2396US10080730B2Treatment of vasculopathy with prostacyclin and mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 25, 2018·23 cites·11 claims
- 2496US10076505B2Inhalation formulations of TreprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Sep 18, 2018·14 cites·7 claims
- 2596US9713599B2Parenteral formulations of treprostinilUNITED THERAPEUTICS CORP·Filed 2015·Granted Jul 25, 2017·18 cites·5 claims
- 2696US9701611B2Salts of treprostinilUNITED THERAPEUTICS CORP·Filed 2016·Granted Jul 11, 2017·8 cites·38 claims
- 2796US7879909B2Use of Treprostinil to treat neuropathic diabetic foot ulcersUNITED THERAPEUTICS CORP·Filed 2005·Granted Feb 1, 2011·63 cites·21 claims
- 2896US6803386B2Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancerUNITED THERAPEUTICS CORP·Filed 2002·Granted Oct 12, 2004·89 cites·16 claims
- 2995US11826328B2Stable treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2021·Granted Nov 28, 2023·2 cites·10 claims
- 3095US10947177B2Compounds and methods for delivery of prostacyclin analogsUNITED THERAPEUTICS CORP·Filed 2019·Granted Mar 16, 2021·3 cites·48 claims
- 3195US9758465B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2014·Granted Sep 12, 2017·24 cites·16 claims
- 3295US9102660B2Process of making prostacyclin compounds with linker thiol and pegylated formsUNITED THERAPEUTICS CORP·Filed 2014·Granted Aug 11, 2015·34 cites·23 claims
- 3395US7999007B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2008·Granted Aug 16, 2011·52 cites·26 claims
- 3495US6756033B2Method for delivering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2002·Granted Jun 29, 2004·124 cites·10 claims
- 3595US6521212B1Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalationUNITED THERAPEUTICS CORP·Filed 2000·Granted Feb 18, 2003·149 cites·12 claims
- 3695US6242482B1Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failureUNITED THERAPEUTICS CORP·Filed 2000·Granted Jun 5, 2001·84 cites·51 claims
- 3794US11723887B2Process to prepare treprostinil, the active ingredient in Remodulin®UNITED THERAPEUTICS CORP·Filed 2019·Granted Aug 15, 2023·2 cites·11 claims
- 3894US10494327B2Controlled release pharmaceutical formulationsUNITED THERAPEUTICS CORP·Filed 2017·Granted Dec 3, 2019·11 cites·16 claims
- 3994US9593066B2Process to prepare treprostinil, the active ingredient in remodulin®UNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 14, 2017·9 cites·10 claims
- 4094US8653137B2Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using sameUNITED THERAPEUTICS CORP·Filed 2013·Granted Feb 18, 2014·34 cites·13 claims
- 4194US7199157B2Use of treprostinil to improve kidney functionsUNITED THERAPEUTICS CORP·Filed 2004·Granted Apr 3, 2007·120 cites·13 claims
- 4294US6809223B2Process for stereoselective synthesis of prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2003·Granted Oct 26, 2004·121 cites·4 claims
- 4393US11634443B2Treprostinil prodrugsUNITED THERAPEUTICS CORP·Filed 2020·Granted Apr 25, 2023·2 cites·16 claims
- 4493US10376525B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2016·Granted Aug 13, 2019·13 cites·4 claims
- 4593US10071123B2Treatment of pulmonary arterial hypertension with mesenchymal stem cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Sep 11, 2018·21 cites·3 claims
- 4693US10016463B2Treatment of pulmonary arterial hypertension with prostacyclin-treated endothelial progenitor cellsUNITED THERAPEUTICS CORP·Filed 2013·Granted Jul 10, 2018·19 cites·16 claims
- 4793US9988334B2Salts of treprostinilUNITED THERAPEUTICS CORP·Filed 2017·Granted Jun 5, 2018·3 cites·15 claims
- 4893US9604901B2Process to prepare treprostinil, the active ingredient in Remodulin®UNITED THERAPEUTICS CORP·Filed 2015·Granted Mar 28, 2017·7 cites·9 claims
- 4993US7715905B2Cooperative processing with mobile monitoring device and computer systemUNITED THERAPEUTICS CORP·Filed 2005·Granted May 11, 2010·89 cites·26 claims
- 5093US2025002442A1Synthesis of intermediates for producing prostacyclin derivativesUNITED THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
Showing the top 50 of 188 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →